Matthew Hall is our Vice President of Clinical Development Operations. He leads the operation, execution, strategy and vendor management for Marinus’ domestic phase 1 & 2 and global phase 3 clinical trials.

Mr. Hall has over 25 years of experience in medical / dental device, clinical drug development, clinical operations and medical affairs. Under his leadership, the Clinical Development Operations team has capitalized on efficiencies, quality and cost savings by internalizing key functions to enhance essential infrastructure, quality deliverables and control of clinical trial data. Before joining Marinus, Mr. Hall held titles of Director of North American Clinical Operations and Director of US Medical Affairs at Teva Pharmaceuticals. There, he led teams responsible for successfully executing numerous phase 1 – 4 domestic and global clinical trials in CNS, oncology, women’s health, endocrinology and mental illness therapeutic areas.

In addition, Mr. Hall led multiple MSL teams responsible for pre and post launch activities, providing medical / scientific support for several CNS and women’s health approved drugs.  Prior to Teva, he held roles of increasing responsibility at Barr Laboratories, Pharmanet, PPD, Clinical Research Associates and authored / co-authored nine published papers in the Journal of Dental Research.  Mr. Hall holds a B.S in Human Biology from the University of Utah.